Regenosine
3 known investors
Regenosine is developing a regenerative therapy for osteoarthritis and other indications, based on an intra-articular injection of a proprietary liposomal adenosine formula designed for slow release in joints. The therapy is positioned as disease-modifying, aiming to reduce joint pain, halt disease progression, and promote cartilage regeneration.
BiotechHealthtechMedical Devices
Investors · 3
Frequently asked questions
- What does Regenosine do?
- Regenosine is developing a regenerative therapy for osteoarthritis and other indications, based on an intra-articular injection of a proprietary liposomal adenosine formula designed for slow release in joints. The therapy is positioned as disease-modifying, aiming to reduce joint pain, halt disease progression, and promote cartilage regeneration.
- Who are Regenosine's investors?
- Regenosine's investors include Beresford Ventures, NYU Innovation Venture Fund, Tech Council Ventures.